Skye Bioscience, Inc. Common Stock (SKYE) — Working Capital to Net Assets Ratio
Skye Bioscience, Inc. Common Stock (SKYE) has a Working Capital to Net Assets ratio of 90.6% as of March 2026. Working capital of $8.16 Million (current assets of $18.57 Million minus current liabilities of $10.40 Million) is measured against net assets of $9.01 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See SKYE FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Skye Bioscience, Inc. Common Stock Working Capital to Net Assets (2012–2025)
This chart shows how Skye Bioscience, Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 90.6%, reflecting working capital of $8.16 Million against net assets of $9.01 Million USD. See Skye Bioscience, Inc. Common Stock defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Skye Bioscience, Inc. Common Stock (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Skye Bioscience, Inc. Common Stock from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Skye Bioscience, Inc. Common Stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 94.3% | $18.89 Million | $20.02 Million | $27.09 Million | $8.21 Million | ▼ -3.2 pp |
| 2024 | 97.6% | $66.49 Million | $68.15 Million | $70.83 Million | $4.34 Million | ▼ -8.0 pp |
| 2023 | 105.6% | $-2.25 Million | $-2.13 Million | $11.65 Million | $13.90 Million | ▼ 0.0 pp |
| 2022 | 105.6% | $-3.18 Million | $-3.01 Million | $8.94 Million | $12.12 Million | ▲ +8.4 pp |
| 2021 | 97.2% | $5.70 Million | $5.86 Million | $9.61 Million | $3.91 Million | ▼ -319.2 pp |
| 2020 | 416.4% | $1.88 Million | $450.79K | $2.66 Million | $787.20K | ▲ +229.6 pp |
| 2019 | 186.8% | $1.02 Million | $548.06K | $1.99 Million | $970.82K | ▲ +97.0 pp |
| 2018 | 89.9% | $-13.99 Million | $-15.56 Million | $1.95 Million | $15.94 Million | ▲ +58.6 pp |
| 2017 | 31.3% | $-250.16K | $-800.08K | $555.81K | $805.97K | ▲ +4.9 pp |
| 2016 | 26.4% | $-382.47K | $-1.45 Million | $279.49K | $661.96K | ▼ -583.4 pp |
| 2015 | 609.8% | $2.87 Million | $471.00K | $3.45 Million | $581.86K | ▲ +501.1 pp |
| 2014 | 108.6% | $-492.69K | $-453.55K | $308.40K | $801.09K | ▼ -99.9 pp |
| 2013 | 208.5% | $-76.02K | $-36.46K | $106.13K | $182.15K | ▲ +120.3 pp |
| 2012 | 88.2% | $34.02K | $38.56K | $38.35K | $4.33K | — |